Tritace Comp 2.5/12.5 Tritace Comp 5/25
... must be carefully weighed out against the risk of volume overload). ...
... must be carefully weighed out against the risk of volume overload). ...
Nursing Management of the Patient with Multiple Sclerosis
... Reference Series for Clinical Practice, to meet its members’ needs for educational tools. To better reflect the nature of the guidelines and the organization’s commitment to developing each guideline based on current literature and evidence-based practice, the name of the series was changed in 2007 ...
... Reference Series for Clinical Practice, to meet its members’ needs for educational tools. To better reflect the nature of the guidelines and the organization’s commitment to developing each guideline based on current literature and evidence-based practice, the name of the series was changed in 2007 ...
Chronic Use of Opioid Analgesics in Non-Malignant Pain
... treated with opioids and non-malignant pain patients not receiving opioids significantly different at P < 0.05. **Non-malignant pain patients treated with opioids and cancer pain patients significantly different at P < 0.05. ...
... treated with opioids and non-malignant pain patients not receiving opioids significantly different at P < 0.05. **Non-malignant pain patients treated with opioids and cancer pain patients significantly different at P < 0.05. ...
Persistent burnout theory of chronic fatigue syndrome
... Anecdotally, patients seem to use a variety of unproven treatments that sometimes lead to recovery. The only common factors among all these treatments seem to be self-efficacy and the achievement of positive goals. Low self-efficacy has been shown to be a risk factor for both burnout and CFS,34,35 a ...
... Anecdotally, patients seem to use a variety of unproven treatments that sometimes lead to recovery. The only common factors among all these treatments seem to be self-efficacy and the achievement of positive goals. Low self-efficacy has been shown to be a risk factor for both burnout and CFS,34,35 a ...
Diagnostic and Clinical Care Guidelines for Primary Immunodeficiency
... be determined molecular basis. Because most of these are lifelong conditions, it is very important to perform a detailed diagnostic evaluation before initiating therapies that will be continued in an open-ended fashion. The guidelines that follow ...
... be determined molecular basis. Because most of these are lifelong conditions, it is very important to perform a detailed diagnostic evaluation before initiating therapies that will be continued in an open-ended fashion. The guidelines that follow ...
Dexamethasone Intravitreal Implant for Treatment of Patients With
... by 1 month after treatment with a dexamethasone implant, and the improvement remained statistically significant throughout the 6-month study. The peak effectiveness of dexamethasone implants was seen at 3 months after injection, when mean FT had decreased by 41%, and the mean BCVA improved to 0.37 6 ...
... by 1 month after treatment with a dexamethasone implant, and the improvement remained statistically significant throughout the 6-month study. The peak effectiveness of dexamethasone implants was seen at 3 months after injection, when mean FT had decreased by 41%, and the mean BCVA improved to 0.37 6 ...
Managing Medication in the Last Years, Months and Days of Life
... Managing Medication in the Last Years, Months and Days of Life – Top Tips: Commissioned by THCCG: For review December 2014 Individualised care is paramount. This guidance does not aim to give ‘dos and don’ts’, but instead provides professionals with a set of principles that can be applied in a wide ...
... Managing Medication in the Last Years, Months and Days of Life – Top Tips: Commissioned by THCCG: For review December 2014 Individualised care is paramount. This guidance does not aim to give ‘dos and don’ts’, but instead provides professionals with a set of principles that can be applied in a wide ...
Acute Intermittent Porphyria
... cases of AIP, with the facial (VII) and vagus (X) nerves being involved more than the others. Visual impairment, including blindness, has been reported and is believed to be secondary to involvement of the optic (II) nerve or occipital lobes.5 Other physical signs include hypertension (which may per ...
... cases of AIP, with the facial (VII) and vagus (X) nerves being involved more than the others. Visual impairment, including blindness, has been reported and is believed to be secondary to involvement of the optic (II) nerve or occipital lobes.5 Other physical signs include hypertension (which may per ...
Alcon Contoura Supplement
... Now that T-CAT is approved in the U.S., it is important for eye surgeons who want to effectively position it in their practice to choose patients who will respond similarly to the subjects who were treated in the FDA study. The ophthalmic community in the U.S. has been eagerly awaiting T-CAT with go ...
... Now that T-CAT is approved in the U.S., it is important for eye surgeons who want to effectively position it in their practice to choose patients who will respond similarly to the subjects who were treated in the FDA study. The ophthalmic community in the U.S. has been eagerly awaiting T-CAT with go ...
Baxter and Halozyme Announce Collaboration
... development, manufacturing, clinical, regulatory, sales and marketing costs. Halozyme will be responsible for the supply of the recombinant human hyaluronidase (rHuPH20) enzyme that provides the basis for Enhanze Technology. Upon regulatory approval, Halozyme will also receive royalties on GAMMAGARD ...
... development, manufacturing, clinical, regulatory, sales and marketing costs. Halozyme will be responsible for the supply of the recombinant human hyaluronidase (rHuPH20) enzyme that provides the basis for Enhanze Technology. Upon regulatory approval, Halozyme will also receive royalties on GAMMAGARD ...
Increased risk of Alzheimer`s disease in Type II diabetes: insulin
... uncertainty remains into the exact pathogenesis, several mechanisms through which DM2 may affect the brain have now been identified. First, factors related to the ‘metabolic syndrome’, a cluster of metabolic and vascular risk factors (e.g. dyslipidaemia and hypertension) that is closely linked to DM2 ...
... uncertainty remains into the exact pathogenesis, several mechanisms through which DM2 may affect the brain have now been identified. First, factors related to the ‘metabolic syndrome’, a cluster of metabolic and vascular risk factors (e.g. dyslipidaemia and hypertension) that is closely linked to DM2 ...
Sulbactam/Cefoperazone Versus Cefotaxime for the Treatment of
... laboratory test results were in accordance with diagnostic criteria for moderate-to-severe bacterial infections and if they had not received effective antimicrobial treatment within 48 hours of study enrollment. The scoring for assessment of moderateto-severe infections of the respiratory tract or u ...
... laboratory test results were in accordance with diagnostic criteria for moderate-to-severe bacterial infections and if they had not received effective antimicrobial treatment within 48 hours of study enrollment. The scoring for assessment of moderateto-severe infections of the respiratory tract or u ...
INFLAMMATORY INDEX AND TREATMENT OF BRAIN ABSCESS
... 32,300/mm3) at the time of admission.1,8,9,16) The CRP was elevated to a high level (2–21.6 mg/ dl) in 69.2–71.4% of patients on admission,7,16,17) and 25.6–50% of abscess patients were febrile (37.8–39.8°C) at the time of admission.1,8,9) However, the value of these inflammatory indices were genera ...
... 32,300/mm3) at the time of admission.1,8,9,16) The CRP was elevated to a high level (2–21.6 mg/ dl) in 69.2–71.4% of patients on admission,7,16,17) and 25.6–50% of abscess patients were febrile (37.8–39.8°C) at the time of admission.1,8,9) However, the value of these inflammatory indices were genera ...
Successful Treatment of Amegakaryocytic Thrombocytopenia With
... most stages of B cells, such as immature B cells, naïve B cells, memory B cells, and germinal center B cells, but not early pro-B cells or plasma cells. Rituximab may suppress pathogenic B-cell clones that produce anti-TPO receptor antibodies that are resistant to conventional immunosuppressive ther ...
... most stages of B cells, such as immature B cells, naïve B cells, memory B cells, and germinal center B cells, but not early pro-B cells or plasma cells. Rituximab may suppress pathogenic B-cell clones that produce anti-TPO receptor antibodies that are resistant to conventional immunosuppressive ther ...
irritable bowel syndrome - American College of Gastroenterology
... Sometimes patients are willing to undergo surgery because their pain is so severe. Studies have shown that surgery done only for an indication of IBS-like pain is usually not helpful in finding the cause of the patient’s pain or leading to improvement in the patient’s pain symptoms. How is IBS Trea ...
... Sometimes patients are willing to undergo surgery because their pain is so severe. Studies have shown that surgery done only for an indication of IBS-like pain is usually not helpful in finding the cause of the patient’s pain or leading to improvement in the patient’s pain symptoms. How is IBS Trea ...
Reactivation of cytomegalovirus in a patient with Stevens
... SJS and TEN are severe adverse cutaneous drug reactions that predominantly involve the skin and mucous membranes.4,5 The diagnosis relies on clinical symptoms and histological features.1 Treatment with corticosteroids is recommended, but is not necessarily effective.5-7 Several drugs can induce SJS/ ...
... SJS and TEN are severe adverse cutaneous drug reactions that predominantly involve the skin and mucous membranes.4,5 The diagnosis relies on clinical symptoms and histological features.1 Treatment with corticosteroids is recommended, but is not necessarily effective.5-7 Several drugs can induce SJS/ ...
Ivermectin Tablets USP, 3 mg
... Clinical studies of ivermectin did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, tre ...
... Clinical studies of ivermectin did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, tre ...
in-depth article about collagenous and lymphocytic colitis
... folate replacement is suggested. Serious idiosyncratic reactions such as hepatitis, pancreatitis, alveolitis, and serum sickness are rare. Sulfasalazine should be discontinued if the patient experiences major side effects such as allergic skin reaction, hemolysis, neutropenia, or milder allergic rea ...
... folate replacement is suggested. Serious idiosyncratic reactions such as hepatitis, pancreatitis, alveolitis, and serum sickness are rare. Sulfasalazine should be discontinued if the patient experiences major side effects such as allergic skin reaction, hemolysis, neutropenia, or milder allergic rea ...
A Randomized, Double Blind, Placebo
... lasting as long as 20 months have also been described.15,20,21 These long-term studies demonstrated that sodium oxybate therapy alleviated the signs and symptoms of narcolepsy with no evidence of tolerance in doses ranging from 2.5 g-7 g nightly. The objectives of the present study were to evaluate ...
... lasting as long as 20 months have also been described.15,20,21 These long-term studies demonstrated that sodium oxybate therapy alleviated the signs and symptoms of narcolepsy with no evidence of tolerance in doses ranging from 2.5 g-7 g nightly. The objectives of the present study were to evaluate ...
The Vulvodynia Guideline - National Vulvodynia Association
... Results. Vulvodynia has been redefined by the International Society for the Study of Vulvovaginal Disease as vulvar discomfort in the absence of gross anatomic or neurologic findings. Classification is based further on whether the pain is generalized or localized and whether it is provoked, unprovok ...
... Results. Vulvodynia has been redefined by the International Society for the Study of Vulvovaginal Disease as vulvar discomfort in the absence of gross anatomic or neurologic findings. Classification is based further on whether the pain is generalized or localized and whether it is provoked, unprovok ...
Dry eye Part 2 Current therapeutic and management options
... While individual patients may claim benefit from a number of different foodstuffs, based on scientific evidence, the only dietary components consistently shown to improve dry eye signs and symptoms are the essential fatty acids.3, 4 Essential fatty acids are required by the body but cannot be synthe ...
... While individual patients may claim benefit from a number of different foodstuffs, based on scientific evidence, the only dietary components consistently shown to improve dry eye signs and symptoms are the essential fatty acids.3, 4 Essential fatty acids are required by the body but cannot be synthe ...
Seminar Series Recurrent Respiratory Papillomatosis
... genital HPV infections; among adults, circumstantial evidence suggests that the disease may be associated with oral-genital contact. Retrospective and recent prospective studies have confirmed that HPV may be passed by vertical transmission from mother to child.-•''"^^ In addition. Kashima et aP' fo ...
... genital HPV infections; among adults, circumstantial evidence suggests that the disease may be associated with oral-genital contact. Retrospective and recent prospective studies have confirmed that HPV may be passed by vertical transmission from mother to child.-•''"^^ In addition. Kashima et aP' fo ...
Motor and Sensory Dysfunction 2015 3. Motor and Sensory
... Motor and Sensory Dysfunction 2015 Five studies examining the effects of BTX-A on spasticity following ABI were identified. Intiso et al. (2014) showed a reduction in spasticity for the upper extremity (elbow, wrist, and hand), as well as ankle joints at one and four months post treatment. Although ...
... Motor and Sensory Dysfunction 2015 Five studies examining the effects of BTX-A on spasticity following ABI were identified. Intiso et al. (2014) showed a reduction in spasticity for the upper extremity (elbow, wrist, and hand), as well as ankle joints at one and four months post treatment. Although ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.